Whole brain radiotherapy (WBRT) for brain metastases

Frédéric Dhermain

doi:10.1007/978-3-030-23417-1_18

Whole brain radiotherapy (WBRT) for brain metastases

Frédéric Dhermain

Résultats de recherche: Le chapitre dans un livre, un rapport, une anthologie ou une collection › !!Chapter › Revue par des pairs

Résumé

WBRT was the historical reference in the management of metastatic patients with brain metastases (BMs) both acting as a palliative tool for symptomatic patients and also by effectively preventing the risk of developing new BMs, including the postoperative setting [1]. To be noted and until the early 2000s, median overall survival (OS) of these patients was usually between 6 and 9 months, and consequently neurocognitive status and quality of life were evaluated with ‘basic’ tools such as the Karnofsky Performance Status (KPS), the MMSE (Mini-Mental Status Exam) or the EORTC QLQ (Quality of Life Questionnaire)-Brain Neurologic (BN-20) module, also due to the lack of time devoted to this clearly ‘palliative’ care.

langue originale	Anglais
titre	Central Nervous System Metastases
Editeur	Springer International Publishing
Pages	239-245
Nombre de pages	7
ISBN (Electronique)	9783030234171
ISBN (imprimé)	9783030234164
Les DOIs	https://doi.org/10.1007/978-3-030-23417-1_18
état	Publié - 1 janv. 2019

Accès au document

10.1007/978-3-030-23417-1_18

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@inbook{2663291d4ee04be88e2e504c77aa8551,

title = "Whole brain radiotherapy (WBRT) for brain metastases",

abstract = "WBRT was the historical reference in the management of metastatic patients with brain metastases (BMs) both acting as a palliative tool for symptomatic patients and also by effectively preventing the risk of developing new BMs, including the postoperative setting [1]. To be noted and until the early 2000s, median overall survival (OS) of these patients was usually between 6 and 9 months, and consequently neurocognitive status and quality of life were evaluated with {\textquoteleft}basic{\textquoteright} tools such as the Karnofsky Performance Status (KPS), the MMSE (Mini-Mental Status Exam) or the EORTC QLQ (Quality of Life Questionnaire)-Brain Neurologic (BN-20) module, also due to the lack of time devoted to this clearly {\textquoteleft}palliative{\textquoteright} care.",

author = "Fr{\'e}d{\'e}ric Dhermain",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2020.",

year = "2019",

month = jan,

day = "1",

doi = "10.1007/978-3-030-23417-1_18",

language = "English",

isbn = "9783030234164",

pages = "239--245",

booktitle = "Central Nervous System Metastases",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Whole brain radiotherapy (WBRT) for brain metastases

AU - Dhermain, Frédéric

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2020.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - WBRT was the historical reference in the management of metastatic patients with brain metastases (BMs) both acting as a palliative tool for symptomatic patients and also by effectively preventing the risk of developing new BMs, including the postoperative setting [1]. To be noted and until the early 2000s, median overall survival (OS) of these patients was usually between 6 and 9 months, and consequently neurocognitive status and quality of life were evaluated with ‘basic’ tools such as the Karnofsky Performance Status (KPS), the MMSE (Mini-Mental Status Exam) or the EORTC QLQ (Quality of Life Questionnaire)-Brain Neurologic (BN-20) module, also due to the lack of time devoted to this clearly ‘palliative’ care.

AB - WBRT was the historical reference in the management of metastatic patients with brain metastases (BMs) both acting as a palliative tool for symptomatic patients and also by effectively preventing the risk of developing new BMs, including the postoperative setting [1]. To be noted and until the early 2000s, median overall survival (OS) of these patients was usually between 6 and 9 months, and consequently neurocognitive status and quality of life were evaluated with ‘basic’ tools such as the Karnofsky Performance Status (KPS), the MMSE (Mini-Mental Status Exam) or the EORTC QLQ (Quality of Life Questionnaire)-Brain Neurologic (BN-20) module, also due to the lack of time devoted to this clearly ‘palliative’ care.

UR - http://www.scopus.com/inward/record.url?scp=85086978798&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-23417-1_18

DO - 10.1007/978-3-030-23417-1_18

M3 - Chapter

AN - SCOPUS:85086978798

SN - 9783030234164

SP - 239

EP - 245

BT - Central Nervous System Metastases

PB - Springer International Publishing

ER -